INFLUENCE OF A MURAMYL DIPEPTIDE ON HUMAN BLOOD LEUKOCYTE FUNCTIONS AND THEIR MEMBRANE-ANTIGENS

被引:17
作者
RIVEAU, GJ
BRUNELRIVEAU, BG
AUDIBERT, FM
CHEDID, LA
机构
[1] Laboratoire d'Lmmunopharmacologie Expérimentale, CNRS UPR 405, Institut Biomédical des Cordeliers, 75006 Paris
关键词
D O I
10.1016/0008-8749(91)90338-C
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Murabutide, which belongs to the immunomodulator family of muramyl peptides, was applied directly to fresh human blood to evaluate changes in leukocyte properties. After blood incubation with murabutide, lymphocytes presented a higher responsiveness to T-mitogens, and monocytes and polymorphonuclear cells exhibited an increase in their capacity to produce hydrogen peroxide. In addition, murabutide treatment enhanced phagocytic activity of neutrophils, whereas monocytes presented a decrease in this activity. Some surface markers were also investigated in the distinct leukocyte populations, After incubation with murabutide, a larger number of lymphocytes expressed Ta1 antigen (CD W26) and transferrin receptor (CD 71). In contrast, expression of interleukin-2 receptor (CD 25) was slightly decreased. Monocytes from treated blood displayed a larger number of receptors for C3bi (CD 11b), whereas the surface marker CD 14 and the class I receptor for the Fc portion of IgG were down-regulated. Activation of polymorphonuclear cells by murabutide was confirmed by the up-regulation of the C3bi receptor, Fc receptor, and CD 14 surface antigen. The effects of murabutide on leukocytes described in this paper may contribute to understanding mechanisms of the modulating activity of muramyl peptides on specific and nonspecific immunity. © 1991.
引用
收藏
页码:147 / 156
页数:10
相关论文
共 38 条
[1]   NEUTROPHIL-ACTIVATING PEPTIDE-1 INTERLEUKIN-8, A NOVEL CYTOKINE THAT ACTIVATES NEUTROPHILS [J].
BAGGIOLINI, M ;
WALZ, A ;
KUNKEL, SL .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04) :1045-1049
[2]  
BAHR GM, 1984, CLIN EXP IMMUNOL, V57, P178
[3]  
BASS DA, 1983, J IMMUNOL, V130, P1910
[4]   MODULATION OF IMMUNE-RESPONSE BY A SYNTHETIC ADJUVANT AND ANALOGS [J].
CHEDID, L ;
AUDIBERT, F ;
LEFRANCIER, P ;
CHOAY, J ;
LEDERER, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (07) :2472-2475
[5]   BIOLOGICAL-ACTIVITY OF A NEW SYNTHETIC MURAMYL PEPTIDE ADJUVANT DEVOID OF PYROGENICITY [J].
CHEDID, LA ;
PARANT, MA ;
AUDIBERT, FM ;
RIVEAU, GJ ;
PARANT, FJ ;
LEDERER, E ;
CHOAY, JP ;
LEFRANCIER, PL .
INFECTION AND IMMUNITY, 1982, 35 (02) :417-424
[6]   PRODUCTION OF LYMPHOCYTE ACTIVATING FACTOR IN THE ABSENCE OF ENDOGENOUS PYROGEN BY RABBIT OR HUMAN-LEUKOCYTES STIMULATED BY A MURAMYL DIPEPTIDE DERIVATIVE [J].
DAMAIS, C ;
RIVEAU, G ;
PARANT, M ;
GEROTA, J ;
CHEDID, L .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1982, 4 (05) :451-462
[7]   INVITRO SPLEEN-CELL RESPONSIVENESS TO VARIOUS ANALOGS OF MDP (N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE), A SYNTHETIC IMMUNOADJUVANT, IN MDP HIGH-RESPONDER MICE [J].
DAMAIS, C ;
PARANT, M ;
CHEDID, L ;
LEFRANCIER, P ;
CHOAY, J .
CELLULAR IMMUNOLOGY, 1978, 35 (01) :173-179
[9]   THE CD14 MONOCYTE DIFFERENTIATION ANTIGEN MAPS TO A REGION ENCODING GROWTH-FACTORS AND RECEPTORS [J].
GOYERT, SM ;
FERRERO, E ;
RETTIG, WJ ;
YENAMANDRA, AK ;
OBATA, F ;
LEBEAU, MM .
SCIENCE, 1988, 239 (4839) :497-500
[10]  
HAFLER DA, 1989, J IMMUNOL, V142, P2590